New Alzheimer's drug VY7523 enters human trials – could it slow the disease?
NCT ID NCT06874621
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 25 times
Summary
This study tests a new drug called VY7523 in 52 people with early Alzheimer's disease. The goal is to see if the drug is safe and how it affects the brain. Some participants get the drug, others get a placebo (a dummy treatment). The study lasts up to 12 months and uses brain scans to check for changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
VYGR Site 124001
Toronto, Ontario, M3B2S7, Canada
-
VYGR Site 124002
Ottawa, Ontario, K1Z1G3, Canada
-
VYGR Site 124003
Montreal, Quebec, H3G1H9, Canada
-
VYGR Site 124004
Montreal, Quebec, H4A3T2, Canada
-
VYGR Site 840002
Wellington, Florida, 33414, United States
-
VYGR Site 840003
Stuart, Florida, 34997, United States
-
VYGR Site 840004
The Villages, Florida, 32162, United States
-
VYGR Site 840005
Delray Beach, Florida, 33445, United States
-
VYGR Site 840006
Orlando, Florida, 32803, United States
-
VYGR Site 840007
Decatur, Georgia, 30030, United States
-
VYGR Site 840008
Stamford, Connecticut, 06905, United States
-
VYGR Site 840009
Matthews, North Carolina, 28105, United States
-
VYGR Site 840010
Lady Lake, Florida, 32159, United States
-
VYGR Site 840011
Plymouth Meeting, Pennsylvania, 19462, United States
-
VYGR Site 840012
Toms River, New Jersey, 08755, United States
-
VYGR Site 840014
Miami, Florida, 33135, United States
-
VYGR Site 840015
Miami, Florida, 33126, United States
-
VYGR Site 840016
Orange, California, 92866, United States
-
VYGR Site 840018
Los Angeles, California, 90033, United States
-
VYGR Site 840020
Winter Park, Florida, 32789, United States
-
VYGR Site 840021
Fort Myers, Florida, 33912, United States
-
VYGR Site 840022
San Francisco, California, 94158, United States
-
VYGR Site 840024
Miami, Florida, 33137, United States
Conditions
Explore the condition pages connected to this study.